This is a type of anemia that is present from birth. It affects the bone marrow, where blood cells are made. In this condition, the red blood cells don't develop properly. This can lead to anemia, which makes people feel tired. It's a less common type of anemia.
Every report comes from a Lived member, sent anonymously.
Have you had Blood Transfusion for Congenital Dyserythropoietic Anemia?
Congenital dyserythropoietic anemia (CDA) is a rare group of inherited blood disorders in which the bone marrow struggles to turn immature red blood cells into normal, mature ones. Many of the developing cells look abnormal, often with two or more nuclei, and are destroyed before or soon after they reach the bloodstream. The result is anemia, a shortage of working red blood cells, which can cause tiredness, weakness and pale skin. Because red cells are also broken down faster than normal, people with CDA often have intermittent yellowing of the skin and eyes (jaundice), an enlarged spleen and gallstones. The body also tends to absorb too much iron from food, which can build up and damage organs over time. Severity varies widely, from mild anemia that goes unnoticed for years to anemia that needs regular blood transfusions. There are several types, numbered I to IV, each with its own genetic cause and somewhat different features. Type II is the most common.
CDA is caused by changes (variants) in genes that guide red blood cell development, and each type traces to a different gene or pair of genes. Knowing the exact gene confirms the type and clarifies how it is inherited. In some people with type I, no causative gene change can be found. Types I and II are inherited in an autosomal recessive pattern: a person is affected only when they receive a changed copy of the gene from each parent. The parents are usually healthy carriers. Type IV and one form of type III are autosomal dominant, meaning one changed copy is enough and an affected parent can pass it on. Nothing a person does causes CDA, although periods of extra strain on the bone marrow can temporarily make the anemia worse.
CDA often comes to light during a workup for anemia in childhood, but mild cases may not be recognized until adulthood. Blood tests usually show anemia along with signs of red cell breakdown, such as raised bilirubin (the yellow pigment behind jaundice). A telling clue is that the reticulocyte count, a measure of new red cells leaving the marrow, is lower than expected for how anemic the person is. Iron tests, including ferritin (a measure of the body's iron stores), are often high rather than low. The diagnosis has traditionally rested on examining a bone marrow sample under the microscope, where the developing red cells show the distinctive abnormalities of each type. Genetic testing, often a panel that checks many anemia genes at once, can now confirm the type and has shortened the path to diagnosis. CDA is frequently mistaken for more common inherited anemias, such as hereditary spherocytosis and other hemolytic anemias (anemias caused by red cell breakdown), because the blood findings overlap. Getting the diagnosis right matters, since follow-up and treatment differ.
Treatment depends on the type and on how severe the anemia is. Many people with mild anemia need no regular treatment beyond monitoring. Some need blood transfusions, either only around birth or during times of extra strain on the bone marrow or, less often, on a regular schedule. People with type I commonly take folic acid, a B vitamin, to replace what the body uses up making extra red cells. Managing iron is a central part of care. Because most people with CDA absorb too much iron even without transfusions, iron levels are checked regularly, and magnetic resonance imaging (MRI) scans can measure iron in the liver and heart. When iron builds up, it is removed either by regular blood draws (phlebotomy) if the anemia is mild enough to allow it, or with iron chelation medicines, which bind iron so the body can excrete it. For type I, injections of interferon alfa, an immune-signaling medicine better known as a hepatitis treatment, can raise hemoglobin and reduce or end the need for transfusions in many people. It is the only treatment aimed specifically at type I. The evidence comes from case reports and small series rather than clinical trials, and side effects such as fever, flu-like symptoms, abdominal pain and diarrhea lead some people to lower the dose or stop. A stem cell (bone marrow) transplant from a donor is the only treatment that can cure CDA. Because it carries serious risks, it is generally considered only for severe anemia that depends on transfusions. Other medicines are being studied, but none is yet an established treatment for CDA. Iron supplements, which treat common iron-deficiency anemia, are not a treatment for CDA and can add to iron buildup, so avoid them (including multivitamins with iron) unless the hematologist advises otherwise.
CDA is lifelong, but its course varies a great deal, even between relatives with the same gene change. Many people with mild disease live largely ordinary lives, with anemia that affects their energy more on some days than others and periodic jaundice. Others need regular transfusions and closer medical care. Anemia can dip when the bone marrow is under extra strain, and energy may fall during those periods. Ongoing follow-up with a hematologist (a blood specialist) focuses on blood counts and, above all, on iron. Iron overload builds quietly and can damage organs such as the liver and heart if left untreated, so regular iron tests and scans, at intervals the hematologist sets, are part of routine care. Some types bring other issues worth watching. Type I can involve differences in the fingers or toes, short stature and early bone thinning (osteoporosis). Type III differs in that iron overload and an enlarged spleen are less common, but it has been linked to changes at the back of the eye and to a blood protein abnormality (monoclonal gammopathy) that the hematologist may check for. Because CDA is rare, care is often shared with a center experienced in inherited anemias, and genetic counseling can help families understand the chance of passing it on.
Ask for an evaluation if you or your child has anemia that has no clear cause, does not improve with iron, or comes with recurring jaundice, an enlarged spleen or gallstones at a young age, especially if relatives have similar problems. If you already have CDA, keep regular appointments for iron monitoring even when you feel well. Contact your care team promptly if you notice increasing tiredness, shortness of breath or a racing heartbeat with ordinary activity, which can mean the anemia has worsened, or if jaundice deepens or comes with pain in the upper right abdomen, which can signal a gallstone problem. People taking interferon should report side effects that make it hard to keep up with treatment, and anyone on a transfusion or chelation program should report new symptoms rather than wait for the next visit. Get emergency care right away for signs that red cells have fallen sharply and the heart is under strain: chest pain, fainting, shortness of breath at rest or sudden marked paleness. For chest pain or fainting, call 911. Jaundice with fever, chills or severe pain in the upper right abdomen also needs emergency care right away, since it can mean an infected or blocked gallbladder or bile duct.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Congenital Dyserythropoietic Anemia is like, what's helped you, or ask the community a question.